BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34970803)

  • 41. Evaluating the Hypothalamic-Pituitary-Thyroid (HPT) Axis in Mice.
    Wondisford FE
    Methods Mol Biol; 2018; 1801():155-161. PubMed ID: 29892823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Hypothalamic Paraventricular Nucleus Is the Center of the Hypothalamic-Pituitary-Thyroid Axis for Regulating Thyroid Hormone Levels.
    Kondo Y; Ozawa A; Kohno D; Saito K; Buyandalai B; Yamada S; Horiguchi K; Nakajima Y; Shibusawa N; Harada A; Yokoo H; Akiyama H; Sasaki T; Kitamura T; Yamada M
    Thyroid; 2022 Jan; 32(1):105-114. PubMed ID: 34726513
    [No Abstract]   [Full Text] [Related]  

  • 43. Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress.
    Helmreich DL; Parfitt DB; Lu XY; Akil H; Watson SJ
    Neuroendocrinology; 2005; 81(3):183-92. PubMed ID: 16020927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of Thyroid Hormone Gatekeepers by Thyrotropin in Tanycytes.
    Chandrasekar A; Schmidtlein PM; Neve V; Rivagorda M; Spiecker F; Gauthier K; Prevot V; Schwaninger M; Müller-Fielitz H
    Thyroid; 2024 Feb; 34(2):261-273. PubMed ID: 38115594
    [No Abstract]   [Full Text] [Related]  

  • 45. Type 1 cannabinoid receptor-containing axons innervate hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons.
    Deli L; Wittmann G; Kalló I; Lechan RM; Watanabe M; Liposits Z; Fekete C
    Endocrinology; 2009 Jan; 150(1):98-103. PubMed ID: 18818298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colchicine treatment differently affects releasable thyrotropin-releasing hormone (TRH) pools in the hypothalamic paraventricular nucleus (PVN) and the median eminence (ME).
    Alexander K; Nikodémová M; Kucerová J; Strbák V
    Cell Mol Neurobiol; 2005 Jun; 25(3-4):681-95. PubMed ID: 16075386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance of the thyroid axis during diet-induced obesity in rodents is controlled at the central level.
    Perello M; Cakir I; Cyr NE; Romero A; Stuart RC; Chiappini F; Hollenberg AN; Nillni EA
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E976-89. PubMed ID: 20858755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin).
    Pang XP; Hershman JM; Mirell CJ; Pekary AE
    Endocrinology; 1989 Jul; 125(1):76-84. PubMed ID: 2500334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glutamatergic innervation of corticotropin-releasing hormone- and thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat.
    Wittmann G; Lechan RM; Liposits Z; Fekete C
    Brain Res; 2005 Mar; 1039(1-2):53-62. PubMed ID: 15781046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are the thyroid and adrenal system alterations linked in depression?
    Mokrani MC; Duval F; Erb A; Gonzalez Lopera F; Danila V
    Psychoneuroendocrinology; 2020 Dec; 122():104831. PubMed ID: 33068950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurotransmitter control of hypothalamic-pituitary-thyroid function in rats.
    Morley JE; Brammer GL; Sharp B; Yamada T; Yuwiler A; Hershman JM
    Eur J Pharmacol; 1981 Mar; 70(3):263-71. PubMed ID: 6112152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRH acts as a multifunctional hypophysiotropic factor in vertebrates.
    Galas L; Raoult E; Tonon MC; Okada R; Jenks BG; Castaño JP; Kikuyama S; Malagon M; Roubos EW; Vaudry H
    Gen Comp Endocrinol; 2009 Oct; 164(1):40-50. PubMed ID: 19435597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axis.
    Nemeroff CB; Bissette G; Martin JB; Brazeau P; Vale W; Kizer JS; Prange AJ
    Neuroendocrinology; 1980 Apr; 30(4):193-9. PubMed ID: 6769064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exposure to monocrotophos pesticide causes disruption of the hypothalamic-pituitary-thyroid axis in adult male goldfish (Carassius auratus).
    Zhang X; Tian H; Wang W; Ru S
    Gen Comp Endocrinol; 2013 Nov; 193():158-66. PubMed ID: 23948368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.
    Yoshino H; Miyamae T; Hansen G; Zambrowicz B; Flynn M; Pedicord D; Blat Y; Westphal RS; Zaczek R; Lewis DA; Gonzalez-Burgos G
    J Physiol; 2011 Oct; 589(Pt 20):4857-84. PubMed ID: 21807615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arcuate nucleus ablation prevents fasting-induced suppression of ProTRH mRNA in the hypothalamic paraventricular nucleus.
    Legradi G; Emerson CH; Ahima RS; Rand WM; Flier JS; Lechan RM
    Neuroendocrinology; 1998 Aug; 68(2):89-97. PubMed ID: 9705575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NEW INSIGHTS INTO THE HYPOTHALAMIC-PITUITARY-THYROID AXIS.
    Duntas LH
    Acta Endocrinol (Buchar); 2016; 12(2):125-129. PubMed ID: 31149076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Voluntary exercise adapts the hypothalamus-pituitary-thyroid axis in male rats.
    Uribe RM; Jaimes-Hoy L; Ramírez-Martínez C; García-Vázquez A; Romero F; Cisneros M; Cote-Vélez A; Charli JL; Joseph-Bravo P
    Endocrinology; 2014 May; 155(5):2020-30. PubMed ID: 24605825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of hypophysiotropic thyrotropin-releasing hormone (TRH)-synthesizing neurons in the hypothalamic paraventricular nucleus of the mouse.
    Kádár A; Sánchez E; Wittmann G; Singru PS; Füzesi T; Marsili A; Larsen PR; Liposits Z; Lechan RM; Fekete C
    J Comp Neurol; 2010 Oct; 518(19):3948-61. PubMed ID: 20737594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucose Increase DAGLα Levels in Tanycytes and Its Inhibition Alters Orexigenic and Anorexigenic Neuropeptides Expression in Response to Glucose.
    Palma-Chavez A; Konar-Nié M; Órdenes P; Maurelia F; Elizondo-Vega R; Oyarce K; López S; Rojas J; Steinberg X; García-Robles MA; Sepúlveda FJ
    Front Endocrinol (Lausanne); 2019; 10():647. PubMed ID: 31620093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.